CONTACT US

1(412) 385-2894

25th Annual Hypertension, Diabetes & Dyslipidemia Conference

25th Annual Hypertension, Diabetes & Dyslipidemia Conference is organized by Continuing Education Company, Inc. (CEC) and will be held from Jun 24 - 26, 2021 at Charleston Gaillard Center, Charleston, South Carolina, United States of America. This Conference is also...
Charleston, South Carolina
25th Annual Hypertension, Diabetes & Dyslipidemia Conference is organized by Continuing Education Company, Inc. (CEC) and will be held from Jun 24 - 26, 2021 at Charleston Gaillard Center, Charleston, South Carolina, United States of America. This Conference is also Available as Virtual Livestream Webcast. Target Audience: This activity is designed for physicians specializing in Internal Medicine, Family Medicine, Geriatric Medicine, Endocrinology, Lipidology and Hypertension. Healthcare clinicians including physician assistants and nurse practitioners specializing in these areas or those managing patients with Hypertension, Diabetes, and/or Hyperlipidemia, alone or in combination, may benefit from this activity. Accreditation: Physicians: AAFP: This live activity, 25th Annual Hypertension, Diabetes, and Dyslipidemia Conference, with a beginning date of June 24, 2021 has been reviewed and is acceptable for up to 15.00 Prescribed credit(s) by the American Academy of Family Physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity. AMA PRA Category 1 Credits™: Continuing Education Company designates this live activity for a maximum of 15 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. ABIM MOC: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 15 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. CFPC: Members of the College of Family Physicians of Canada are eligible to receive 15 MAINPRO-M1 credits for participation in this activity due to reciprocal agreement with the American Academy of Family Physicians. Nurse Practitioners AANPCB: The American Academy of Nurse Practitioners Certification Board (AANPCB) accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME. Nurse Practitioners may receive a maximum of 15 hours of participation, with an estimated 6-10 of which can be used towards Pharmacology, for completing this activity. Overview: This three day intensive conference, held on June 24-26, 2021 in Charleston, South Carolina, addresses all the issues confronting clinicians who treat challenging patients with diabetes, hypertension, and dyslipidemia and how to apply this knowledge to everyday practice. Over the past several years controversies in the appropriate target for Hemoglobin A1C, BP, and LDL-Cholesterol on outcome improvement continue to occur in Type 2 diabetes, Hypertension, and Dyslipidemia, respectively. Despite the results from the ACCORD, VADT, and ADVANCE studies suggesting the benefits of reducing A1C on macrovascular disease with a more intensive strategy remains unclear, and even harmful, individualized A1C targets for those with newly diagnosed diabetes are often recommended. In addition, controversy continues to exist in cholesterol control as recent guidelines suggest that one should decide on the intensity of statin-based therapy in those at risk for or with established ASCVD rather than a specific LDL-cholesterol goal to improve clinical outcome. Finally, the recent SPRINT trial found that lower targets for BP reduction can and should be achieved in high-risk adults with hypertension. This conference will address these and other issues confronting the clinician who treats challenging patients with diabetes, hypertension, and dyslipidemia. The participant will learn the most current information on these issues and will be able to apply these important clinical principles back to their everyday practice to improve the care of their patients. Program Objectives: As a result of this educational activity, participants should be better able to: • Formulate an efficient and effective assessment and monitoring plan of a patient's condition as it relates to hypertension, diabetes, and dyslipidemia. • Utilize current guidelines in the diagnosis and management of diabetes, hypertension, and dyslipidemia. • Develop individualized interventions and treatment strategies for patients presenting with hypertension, diabetes, and/or dyslipidemia that will translate into improved long-term outcomes. Additional details will be posted as soon as information is available.
support@emedevents.com
1(800) 828-2059
Oncology